Baseline Urate Level and Renal Function Predict Outcomes of Urate-Lowering Therapy Using Low Doses of Febuxostat and Benzbromarone: A Prospective, Randomized Controlled Study in a Chinese Primary Gout Cohort

Arthritis Research & Therapy
doi 10.1186/s13075-019-1976-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gout Prevalence and Predictors of Urate-Lowering Therapy Use: Results From a Population-Based Study

Arthritis Research & Therapy
2018English

Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients Without Gout: A Case-Matched Cohort Study

PLoS ONE
Multidisciplinary
2015English

Erratum To: Comparative Effectiveness of Urate Lowering With Febuxostat Versus Allopurinol in Gout: Analyses From Large U.S. Managed Care Cohort

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

The Urate-Lowering Efficacy and Safety of Febuxostat in the Treatment of the Hyperuricemia of Gout: The CONFIRMS Trial

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Prophylaxis of Acute Arthritis at Initiation of Urate-Lowering Therapy in Gout Patients

2020English

Gout, Urate-Lowering Therapy, and Uric Acid Levels Among Adults in the United States

Arthritis Care and Research
Rheumatology
2015English

Quality of Care in Gout: A Clinical Audit on Treating to the Target With Urate Lowering Therapy in Real-World Gout Patients

Rheumatology International
RheumatologyAllergyImmunology
2017English

Adequacy of Online Patient Information Resources on Gout and Potentially Curative Urate-Lowering Treatment

Arthritis Care and Research
Rheumatology
2017English

Urate Transporters: Transforming the Face of Hyperuricemia and Gout

Journal of Rheumatology
RheumatologyAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy